Primer on the Gene Ontology by Gaudet, Pascale et al.
  
Primer on the Gene Ontology 
 
Pascale Gaudet​1,*​, Nives Škunca​2,3,4​, James C. Hu​5​, and Christophe Dessimoz​4,6 
 
1​SIB Swiss Institute of Bioinformatics, 1 Michel-Servet, 1211 Geneva, Switzerland 
2​ETH Zurich, Computer Science, Universitätstr. 19, 8092 Zurich, Switzerland 
3​SIB Swiss Institute of Bioinformatics, Universitätstr. 19, 8092 Zurich, Switzerland 
4​University College London, Gower St, London WC1E 6BT, UK 
5​Department of Biochemistry and Biophysics, Texas A&M University and Texas AgriLife 
Research, College Station, TX USA 
6​Department of Ecology and Evolution and Center of Integrative Genomics, University of 
Lausanne, Biophore, 1015 Lausanne, Switzerland 
 
*Corresponding author: pascale.gaudet@isb-sib.ch  
January 2016  
 
Abstract 
The Gene Ontology (GO) project is the largest resource for cataloguing gene 
function. The combination of solid conceptual underpinnings and a practical 
set of features have made the GO a widely adopted resource in the research 
community and an essential resource for data analysis. In this chapter, we 
provide a concise primer for all users of the GO. We briefly introduce the 
1 
structure of the ontology and explain how to interpret annotations 
associated with the GO.  
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1. Introduction 
The key motivation behind the Gene Ontology (GO) was the observation that similar genes often 
have conserved functions in different organisms ​(1)​. Clearly, a common vocabulary was needed 
to be able to compare the roles of orthologous genes (and their products) across different 
species. The value of comparative studies of biological function across systems predates 
Jacques Monod’s statement that ​"anything found to be true of ​E. coli ​must also be true of 
elephants" ​(2)​. ​The Gene Ontology aims to produce a rigorous shared vocabulary to describe the 
roles of genes across different organisms​  ​(1)​. ​The GO project consists of the ​Gene Ontology 
itself, which models biological aspects in a structured way, and ​annotations​, which associate 
genes or gene products with terms from the Gene Ontology.​ Combining information from all 
organisms in one central repository makes it possible to integrate knowledge from different 
databases, to infer the functionality of newly discovered genes, and to gain insight into the 
conservation and divergence of biological subsystems. 
In this primer, we review the fundamentals of the GO project. The chapter is organised as 
answers to five essential questions: What is the GO? Why use it? Who develops it and provides 
annotations? What are the elements of a GO annotation? And finally, how can the reader learn 
more about GO resources? 
2. What is the Gene Ontology?  
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The Gene Ontology is a controlled vocabulary of terms to represent biology in a 
structured way. The terms are subdivided in three distinct ontologies that represent different 
biological aspects: Molecular Function (MF), Biological Process (BP), and Cellular Component 
(CC) ​(1)​. These ontologies are non-redundant and share a common space of identifiers and a 
well-specified syntax.  
Terms are linked to each other by relations to form a hierarchical vocabulary (​add ref to 
Janna Hasting's chapter)​. This is often modelled as a graph in which the relationships form the 
directed edges, and the terms are the nodes (Figure 1). Since each term can have multiple 
relationships to broader parent terms and to more specific child terms, the structure allows for 
more expressivity than a simple hierarchy.  
The full GO is large: in October 2015, the full ontology specification had 43835 terms, 
73776 explicitly encoded ​is_a​ relationships, 7436 explicitly encoded ​part_of​ relationships, 
and 8263 explicitly encoded ​regulates, negatively_regulates ​or 
positively_regulates​ relationships. This level of detail is not necessary for all applications. 
Many research groups who do GO annotations for specific projects use the generic GO-slim file, 
which is a manually curated subset of the Gene Ontology containing general, high-level terms 
across all biological aspects. There are several GO slims , ranging from the general Generic GO 1
slim developed by the GO Consortium to more specific ones, such as the Chembl Drug Target 
slim (http://wwwdev.ebi.ac.uk/chembl/target/browser) .  
1 ​http://geneontology.org/page/go-slim-and-subset-guide  
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Figure 1:​ The structure of the Gene Ontology (GO) is illustrated on a subset of the paths of the 
term “regulation of cell projection assembly,” GO:0060491, to its root term. The GO is a directed 
graph with terms as nodes and relationships as edges; these relationships are either ​is_a​, 
part_of​, ​has_part​, or ​regulates​. In its basic representation, there should be no cycles in 
this graph, and we can therefore establish parent (more general) and child (more specific) terms 
(see Chap. ​XX​ for more details on the different representations; ​cross-reference to Moni’s 
chapter​). Note that it is possible for a term to have multiple parents. This figure is based on the 
visualization available from the AmiGO browser, generated on November 6, 2015. ​(3)​.  
 
To keep up with the current state of knowledge, as well as to correct inaccuracies, the 
GO undergoes frequent revisions: changes of relationships between terms, addition of new 
terms, or term removal (obsoletion). Terms are never deleted from the ontology, but their status 
changes to obsolete and all relationships to the term are removed ​(4)​. Furthermore, the name 
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itself is preceded by the word “obsolete” and the rationale for the obsoletion is typically found in 
the Comment field of the term. An example of an obsolete term is GO:0000005, “obsolete 
ribosomal chaperone activity.” This MF GO term was made obsolete “because it refers to a class 
of gene products and a biological process rather than a molecular function” . Changes to the 2
relationships​ do not impact annotations, because annotations are associated with a given GO 
term regardless of its relationships to other terms within the GO. Obsoletion of terms however 
have an impact on ​annotations ​associated with them: in some cases, the old term can be 
automatically replaced by a new or a parent one; in others, the change is so important that the 
annotations must be manually reviewed.  
However, these changes can affect the analyses done using the ontology. In articles or 
reports, it is good practice to provide the version of the file used for a particular analysis. In GO, 
the version number is the date the file was obtained from the GO site (GO files are updated 
daily). 
3. Why use the Gene Ontology?  
Because it provides a standardised vocabulary for describing gene and gene product 
functions and locations, the GO can be used to query a database in search of genes' function or 
location within the cell or to search for genes that share characteristics ​(5)​. The hierarchical 
structure of the GO allows to compare proteins annotated to different terms in the ontology, as 
long as the terms have relationships to each other. Terms located close together in the ontology 
graph (i.e., with a few intermediate terms between them) tend to be semantically more similar 
than those further apart (​see Chap. of Catia Pesquita on comparing terms​).  
The GO is frequently used to analyse the results of high-throughput experiments. One 
common use is to infer commonalities in the location or function of genes that are over- or 
under-expressed ​(4, 6)​ [​+cross-reference to Sebastian Bauer’s chapter]​. In functional profiling, 
2 ​https://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0000005  
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the GO is used to determine which processes are different between sets of genes. This is done 
by using a likelihood-ratio test to determine if GO terms are represented differently between the 
two gene sets ​(4)​.  
Additionally, the GO can be used to infer the function of unannotated genes. Gene 
predictions with significant similarity to annotated genes can be assigned one or several of the 
functions of the characterized genes. Other methods such as the presence of specific protein 
domains can also be used to assign GO terms ​(7, 8)​. This is discussed in Chap. XX (​x-ref to 
Cozzetto and Jones​). 
A wealth of tools—web-based services, standalone software, and programing 
interfaces—has been developed for applying the GO to various tasks. Some of these are 
presented in Chap. XXX (​x-ref to Moni Munoz-Torres’s chapter​). 
While Gene Ontology resources facilitate powerful inferences and analyses, researchers 
using the GO should familiarise themselves with the structure of the ontology and also with the 
methods and assumptions behind the tools they use to ensure that their results are valid. 
Common pitfalls and remedies are detailed in Chap. XX (​x-ref to Gaudet and Dessimoz chapter​).  
4. Who develops the GO and produces annotations?  
The GO Consortium consists of a number of large databases working together to define 
standardised ontologies and provide annotations to the GO ​(9)​. The groups that constitute the 
GO consortium include UniProt ​(10)​, Mouse Genome Informatics ​(11)​, ​Saccharomyces​ Genome 
Database ​(12)​, Wormbase ​(13)​, Flybase ​(14)​, dictyBase ​(15)​, and TAIR ​(16)​. In addition, several 
other groups contribute annotations, such as EcoCyc ​(17)​ and the Functional Gene Annotation 
group at University College London ​(18) .  Within each group, biocurators assign annotations 3
according to their expertise ​(19)​. Further, the GO Consortium has mechanisms by which 
3 Full list at ​http://geneontology.org/page/go­consortium­contributors­list 
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members of the broader community (​see chapter on Community Annotations​) can suggest 
improvements to the ontology and annotations. 
5. What are the elements of a GO annotation? 
This section describes the different elements composing an annotation and some 
important considerations about each of them. The annotation process from a curator standpoint 
is discussed in detail in the chapter by Gaudet and Poux (​cross-reference​).  
Fundamentally, a GO annotation is the association of a gene product with a GO term. 
From its inception, the GO Consortium has recognized the importance of providing supporting 
information alongside this association. For instance, annotations always include information 
about the evidence supporting the annotation.  
Over time, the GO Consortium standards for storing annotations have evolved to improve 
this representation. Annotations are now stored in one of two formats: GAF (Gene Association 
File), and the more recent GPAD (Gene Product Association Data). The two formats contain the 
same information but there are differences in how the data is normalised and represented 
(discussed in more details in Chap. XXX, ​x-ref to Monica Munoz-Torres’s chapter​). In this primer, 
we focus on the former. The representation of an annotation in the GAF file format 2.1 is shown 
in Figure 2. It contains 17 fields (also sometimes referred to as “columns”). We describe them in 
this section. 
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Figure 2. Gene Association File (GAF) 2.1 file format described with example elements.​ In 
the GAF file, each row represents an annotation, consisting of up to 17 tab-delimited fields (or 
columns). This  figure describes these fields in the order in which they are found in the GAF file. 
Light blue colour denotes non-mandatory fields, and these are allowed to be empty in the GAF 
file. The cardinality—the number of elements in the field—is denoted with the symbol(s) in curly 
brackets: {?} indicates cardinality of zero or one; {*} indicates that any cardinality is allowed; {+} 
indicates cardinality of one or more; {1} indicates that cardinality is exactly one; {1,2} indicates 
that cardinality is either one or two. When cardinality is greater than 1, elements in the field are 
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separated with a pipe character or with a comma; the former indicates 'OR' and the latter 
indicates 'AND'. The GO term assigned in column 5 is always the most specific GO term 
possible.  
 
5.1 Annotation object 
The annotation object is the entity associated with a GO term— a gene, a protein, a 
non-protein-coding RNA, a macromolecular complex, or another gene product. Seven fields of 
the GAF file specify the annotation object. Each annotation in the GO is associated with a 
database (field 1) and a database accession number (field 2) that together provide a unique 
identifier for the gene, the gene product, or the complex. For example, the protein record 
P00519 is a database object in the UniProtKB database (Figure 2). The database object symbol 
(field 3), the database object name (field 10), and the database object synonyms (field 11) 
provide additional information about the annotation object. The database object type specifies 
whether the object being annotated is a gene, or a gene product (e.g., protein or RNA; field 12). 
The organism from which the annotation object is derived is captured as the NCBI taxon ID 
(taxon; field 13); the corresponding species name can be found at the NCBI taxonomy website .  4
GO allows capturing isoform-specific data when appropriate, for example UniProtKB 
accession numbers P00519-1 and P00519-2 are the isoform identifiers for isoform 1 and 2 of 
P00519. In this case, the database ID still refers to the main isoform, and an isoform accession is 
included in the GAF file as "Gene Product Form ID" (field 17).  
5.2 GO term, annotation extension, and qualifier 
Three fields are used to specify the function of the annotation object. Field 5 specifies the 
GO term, while field 9 denotes the sub-ontology of GO, either Molecular Function, Biological 
Process, or Cellular Component. While this information is also encoded in the GO hierarchy, 
4 ​http://www.ncbi.nlm.nih.gov/taxonomy  
 
9 
explicitly denoting the sub-ontology allows simplifies parsing of the annotations according to the 
GO aspect.  Field 4 denotes the qualifier. One of three qualifiers can modify the interpretation of 
an annotation: “​contributes_to​”, “​colocalizes_with​” and “​NOT​.” This field is not 
mandatory, but if present it can profoundly change the meaning of an annotation ​(4)​. Thus, while 
the ​producers​ of annotations may omit qualifiers, applications that ​consume​ GO annotations 
must take them into account. The importance of qualifiers is discussed in more detail in Chapter 
XX (​Gaudet and Dessimoz​). 
An additional field, field 16, is a recent addition to combine more than one term or 
concept (protein, cell type, etc.) in the same annotation. For example , if a gene product Slp1 is 5
localized to the plasma membrane of T-cells, the GAF file field 16 would contain the information 
“part_of(CL:0000084 T cell).” Here, CL:0000084 is the identifier for T-cell in the OBO Cell Type 
(CL) Ontology. This is covered in details in Chap. XX (x-ref to Lovering and Huntley’s chapter on 
annotation extensions).  
5.3 Evidence code and reference field 
Three fields in the GAF file describe the evidence used to assert the annotation: the 
Reference (field 6), the Evidence Code (field 7), and the With/From (field 8). The Evidence Code 
informs the type of experiment or analysis that supports the annotation. There are 21 evidence 
codes, which can be grouped in three broad categories: experimental annotations, curated 
non-experimental annotations, and automatically assigned (also known as electronic) 
annotations (Figure 3). The Reference field specifies more details on the source of the 
annotation. For example, when the evidence code denotes an experimentally supported 
annotation, the Reference will contain the PubMed accession ID (or a DOI if no PubMed ID is 
available) of the journal article which underpins the annotation, or a GO_REF identifier that refers 
to a short description of the assignment method, accessible on the GO website . When the 6
5 http://wiki.geneontology.org/index.php/Annotation_Extension#The_basic_format 
6 http://www.geneontology.org/cgi-bin/references.cgi 
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evidence code denotes an automatically assigned annotation, i.e. IEA, the reference will contain 
a GO_REF identifiers that specify more details on the automatic assignment, e.g., annotation via 
the InterPro resource ​(20)​. 
 
Figure 3: GO Evidence Codes and their abbreviations.​ The type of information supporting 
annotations is recorded with Evidence Codes, which can be grouped into three main categories: 
experimental evidence codes, curated non-experimental annotations, and automatically 
assigned annotations. The obsolete evidence code NR (Not Recorded) is not included in the 
figure. Documentation about the different types of automatically assigned annotations can be 
found at ​http://www.geneontology.org/doc/GO.references​. 
 
5.3.1 Experimentally supported annotations 
Annotations based on direct experimental evidence found in the primary literature are denoted 
with the general evidence code EXP (Inferred from Experiment) or, when appropriate, the more 
specific evidence codes IDA (Inferred from Direct Assay), IPI (Inferred from Physical Interaction), 
IMP (Inferred from Mutant Phenotype), IGI (Inferred from Genetic Interaction), and IEP (Inferred 
from Expression Pattern) (Figure 3). These annotations are held in high regard by the community, 
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e.g., ​(21)​, and are often used in applications such as checking the enrichment of a gene set in 
particular functions, finding genes that perform a specific function, or assessing involvement in 
specific specific pathways or processes.  
Another important use of experimentally supported annotations is in providing trustworthy 
training sets for various computational methods that infer function ​(22)​. Used this way, the 
experimentally supported annotations can be amplified to understand more of the growing set of 
newly sequenced genes.  
5.3.2 Curated non-experimental annotations 
Fourteen of the twenty-one evidence codes are associated with manually curated 
non-experimental annotations. Annotations associated with these codes are curated in the sense 
that every annotation is reviewed by a curator, but they are non-experimental in the sense that 
there is no direct experimental evidence in the primary literature underpinning them; instead, 
they are inferred by curators based on different kinds of analyses. 
ISS (Inferred from Sequence or Structural Similarity) is a superclass (i.e., a parent) of ISA 
(Inferred from Sequence Alignment), ISO (Inferred from Sequence Orthology), and ISM (Inferred 
from Sequence Model) evidence codes. Each of the he three sub-categories of ISS should be 
used when only one method was used to make the inference. For example, to improve the 
accuracy of function propagation by sequence similarity, many methods take into account the 
evolutionary relationships among genes. Most of these methods rely on orthology (ISO evidence 
code), because the function of orthologs tends to be more conserved across species than 
paralogs ​(23, 24)​. In a typical analysis, characterised and uncharacterised genes are clustered 
based on sequence similarity measures and phylogenetic relationships. The function of unknown 
genes is then inferred from the function of characterised genes within the same cluster  ​(e.g. 25, 
26)​. 
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Another approach to function prediction entails supervised machine learning based on 
features derived from protein sequence ​(27–30)​ (ISM evidence code). Such approach uses a 
training set of classified sequences to learn features that can be used to infer gene functions. 
Although few explicit assumptions about the complex relationship between protein sequence 
and function are required, the results are dependent on the accuracy and completeness of the 
training data.  
IGC (Inferred from Genomic Context) includes, but is not limited to, such things as identity of 
the genes neighboring the gene product in question (i.e. synteny), operon structure, and 
phylogenetic or other whole genome analysis.  
Relatively new are four evidence codes associated with phylogenetic analyses. IBA (Inferred 
from Biological aspect of Ancestor) and IBD (Inferred from Biological aspect of Descendant) 
indicate annotations that are propagated along a gene tree. Note that the latter is only applicable 
to ancestral genes. The loss of an active site, a binding site or a domain critical for a particular 
function can be annotated using the IKR (Inferred from Key Residues) evidence code. When this 
code is assigned by PAINT, GO’s ​Phylogenetic Annotation and INference Tool​  ​(31)​, this means 
that it is a prediction based on evolutionary neighbors. Finally, negative annotations can be 
assigned to highly divergent sequences using the code IRD (Inferred from Rapid Divergence).  
RCA (inferred from Reviewed Computational Analysis) captures annotations derived from 
predictions based on computational analyses of large-scale experimental data sets, or based on 
computational analyses that integrate datasets of several types, including experimental data (e.g. 
expression data, protein-protein interaction data, genetic interaction data, etc.), sequence data 
(e.g. promoter sequence, sequence-based structural predictions, etc.), or mathematical models. 
Next, there are two types of annotations derived from author statements. Traceable Author 
Statement (TAS) refers to papers where the result is cited, but not the original evidence itself, 
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such as review papers. On the other hand a NAS (Non-traceable Author Statement) refers to a 
statement in a database entry or statements in papers that cannot be traced to another paper. 
The final two evidence codes for curated non-experimental annotations are IC (Inferred by             
Curator) and ND (No biological Data available). If an assignment of a GO term is made using the                  
curator’s expert knowledge, concluding from the context of the available data, but without any              
direct evidence available, the IC evidence code is used. For example, if a eukaryotic protein is                
annotated with the MF term “DNA ligase activity,” the curator can assign the BP term “DNA                
ligation” and CC term “nucleus” with the evidence code IC.  
The ND evidence code indicates that the function is currently unknown (i.e. that no               
characterization of the gene is currently available). Such an annotation is made to the root of the                 
respective ontology to indicate which functional aspect is unknown. Hence, the ND evidence             
code allows users for a subtle difference between unannotated genes (for which the literature              
has not been completely reviewed and thus no GO annotation has been made) and              
uncharacterised genes (GO annotation with ND code). Note that the ND code is also different               
from an annotation with the “NOT” qualifier (which indicates the absence of a particular              
function).  
5.3.3 Automatically assigned annotations 
The evidence code IEA (Inferred from Electronic Annotation) is used for all inferences 
made without human supervision, regardless of the method used. IEA evidence code is by far 
the most abundantly used evidence code. The guiding idea behind computational function 
annotation is the notion that genes with similar sequences or structures are likely to be 
evolutionarily related, and thus, assuming they largely kept their ancestral function, they might 
still have similar functional roles today. For an in-depth discussion of computational methods for 
GO function annotations, refer to Chap. ​XX (chapter by Cozzetto and Jones) or see ​(32)​. 
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5.3.4 Additional considerations about evidence codes 
Biases associated with the different evidence codes are discussed in the chapter by 
Gaudet and Dessimoz (​x-ref​). Note that there is a more extensive Evidence and Conclusion 
Ontology ​(ECO; 33)​, formerly known as the “Evidence Code Ontology”, presented in Chap ​XXX. 
ECO is only partially implemented in the GO: ECOs are displayed in the AmiGO browser, but 
they are not in the GAF file. However, all Evidence Codes used by the GO are found also in ECO. 
There is a general assumption among the GO user community that annotations based on 
experiments are of higher quality compared to those generated electronically, but this has yet to 
be empirically demonstrated. Generally, annotations derived from automatic methods tend to be 
to high level terms, so they may have a lower information value, but they often withstand 
scrutiny. Conversely, experiments are sometimes overinterpreted (see Gaudet and Poux chapter) 
and can also contain inaccuracies.  
5.4 Uniqueness of GO annotations (or lack thereof) 
No two annotations can have the same combination of the following fields: gene/protein 
ID, GO term, evidence code, reference and isoform. Thus one gene can be annotated to the 
same term with more than one evidence code.   
Most GO analyses are gene-based, and therefore it is important in such analyses to make 
sure the list of genes is non-redundant.  However, annotations are often made to larger protein 
sets that include multiple proteins from the same gene. This is particularly evident in UniProt, 
which can contain distinct entries from the TrEMBL (unreviewed) portion of the database that do 
not necessarily represent biologically distinct proteins.  The different entries for the same protein 
or gene are often annotated with identical GO terms, which can bias statistical analyses because 
some genes have many more entries than other genes.  For instance, the set of human proteins 
in UniProt comprises over 70,000 entries, but there are only approximately 20,000 recognized 
human protein coding genes (20,187 reviewed human proteins in the UniProt release of 
 
15 
2015_12).  The GO Consortium has worked with UniProt as well as the Quest for Orthologs 
Consortium to develop “gene-centric” reference proteome lists 
(http://www.uniprot.org/proteomes/) that provide a single “canonical” UniProt entry for each 
protein-coding gene.  These lists are available for many species, and we encourage users 
performing gene-centric GO analyses to use only the annotations for UniProt entries in these 
lists. 
 
6 How can I learn more about Gene Ontology resources? 
Most of the topics introduced in this primer will be treated in more depth and nuance in later 
chapters. Part II focuses on the creation of GO function annotations—we cover in depth the two 
main strategies of creating GO function annotations: manual extraction/curation from the 
literature and computational prediction. Part III describes the main strategies used to evaluate 
their predictive performance. Part IV covers practical uses of the GO annotations: we discuss 
how GO terms and GO annotations can be summed and compared, how enrichment in specific 
GO terms can be analyzed, and how the GO annotations can be visualized. For the advanced 
GO user, part V discusses how the context of a GO annotation is recorded and goes beyond the 
Evidence Codes to describe how to capture more information on the source of an annotation. 
We end with part VI by going beyond GO: we present alternatives to GO for functional 
annotation; we show how a structured vocabulary is used in the context of ​controlled clinical 
terminologies​; and we present how information from different structured vocabularies is 
integrated in one overarching resource.  
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